바로가기 및 건너띄기 링크
본문 바로가기
주메뉴 바로가기

뉴스레터

home > 자료실> 뉴스레터

글자크기

Newsletter September, 2016

Newsletter September, 2016 : 작성자, 작성일, 조회수, 정보 제공
작성자 관리자
작성일 2016-10-17 조회수 1,733

Korea Pharmaceutical Industry Newsletter

      Newsletter  September, 2016  
MainNews
Ilyang Pharma exports US$200M ulcer treatment tech to Russia
Ilyang Pharmaceutical has  signed an agreement to export its technology for its new ulcer treatment Noltec to Russia’s largest pharmaceutical company R-Pharm, the company announced on Sept. 5.
Daehwa Pharma earns approval for world's first oral anti-cancer drug
Daehwa Pharmaceutical announced on Sept. 9 that its oral cancer treatment DHP107 has been granted approval for manufacturing and sales by the Ministry of Food and Drug Safety. DHP107 is a modified version of paclitaxel, a therapy for breast, ovarian, lung and uterine cancers to be taken orally, a first of its kind in the world.
Boryung Pharm signs $27M out-licensing deal with Mexico's Stendhal
South Korea’s pharmaceutical company Boryung Pharm Co. on monday signed a contract to license out its Kanarb franchise with Mexico-based Stendhal International.The contract is valued at $27.23 million in total.
ST Pharm to export $135.50M API to Gilead Ireland
ST Pharm announced on Sept. 19 that it has signed a US$135.50 million contract with Gilead Sciences Ireland to supply anti-viral active pharmaceutical ingredient for hepatitis C treatment.
Korea Pharmaceutical company
Yungjin Pharm. Co., Ltd was established in 1952 and operates as a subsidiary of KT&G Corporation. With their representative products such as Cephalosporin Antibiotic, Antipsychotic, Cardiovascular, Total Nutrition, and etc, Yungjin Pharm has been playing a major role as a forerunner in the Korean pharmaceutical industry for half a century.
Huons, total healthcare innovator has grown to a competent global company, producing original and effective essential medicine and medical products, through continual challenges and innovation over 50 years. Huons, having obtained many patents as the results of its research, is not becoming complacent and is working hard for development of new medicines
2015 혁신형제약기업 소개책자(영문) 기업디렉토리북 포털 링크 기업디렉토리북 포털 링크 바이오의약품산업 디렉토리북(English)
Korea Pharmaceutical company license-out information
 
Products Expected to Export & Technology Transfer
 
- 40 Innovative Pharma Companies have over 300 R&D pipeline
 
pipeline
 
BC World Pharm Yungjin Pharmaceutical Kael GemVax Corestem Pharmicell
 
Handok Hanall BioPharma Hyundai Pharm License Deal list Korea pharm 2016
 
 
khidi mohw biokorea epharma kpma kdra kobia mfds
 

댓글등록

로그인 또는 본인확인 후 작성 가능합니다.

0/250

의견입력영역